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Abstract
Background: The purpose of this study is to investigate cardiovascular benefits of juices obtained from two
commonly consumed fruits in Thailand, Pachyrhizus erosus, L. (yam bean) and Psidium guajava, L. (guava), by
examining their acute cardiovascular effects in healthy volunteers. Possible involvements of the dietary nitrate on
their effects were investigated as well.
Method: Thirty healthy volunteers were randomly divided into three groups of 10 subjects per group and each
group was allocated to drink 500 ml of freshly prepared yam bean root juice, guava fruit juice, or water. Systemic
nitrate and nitrite concentrations, heart rate, systolic and diastolic blood pressure, serum K+ concentrations, ex vivo
platelet aggregation, and plasma cGMP concentrations were monitored at the baseline and at various time points
after the intake of juices or water. Data were compared by repeated measures ANOVA.
Results: Following the ingestion of both yam bean root juice and guava fruit juice, collagen-induced but not
ADP-induced platelet aggregation was attenuated. Ingestion of yam bean root juice increased systemic nitrate
and nitrite concentrations whereby elevated nitrite concentrations correlated with the extent of inhibiting
collagen-induced platelet aggregation. In addition, positive correlation between systemic nitrite and plasma cGMP
concentrations and negative correlation between plasma cGMP concentrations and the extent of collagen-induced
platelet aggregation were revealed. Nevertheless, yam bean root juice reduced only diastolic blood pressure while
guava fruit juice reduced heart rate, systolic and diastolic blood pressure.
Conclusion: The present study has illustrated, for the first time, acute inhibitory effects of yam bean root juice and
guava fruit juice on ex vivo collagen-induced platelet aggregation in healthy subjects. Dietary nitrate was shown
to underlie the effect of yam bean root juice but not that of guava fruit juice. Following yam bean root juice
ingestion, systemic nitrate apparently converts to nitrite and further to NO which may attenuate platelet responses
to collagen stimulation. Cardiovascular benefits of juices from yam bean root and guava fruit are noteworthy in
term of the cardiovascular health-promoting approach.
Trial registration: Randomized controlled trial TCTR20150228001.
Keywords: Yam bean root juice, Guava fruit juice, Systemic nitrate, Systemic nitrite, Plasma cGMP, Antiplatelet
effect, Blood pressure lowering effect
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Background
Decreased production of nitric oxide (NO) is evident in
essential hypertension and other conditions associated
with elevated blood pressure such as diabetes, hyper-
cholesterolemia, and chronic kidney disease [1–6]. Evi-
dence from both human and animal studies showed that
nitrate and nitrite derived from diet can serve as a
source for NO particularly where it is deficient [7–10],
which was firstly demonstrated by Appel and coworkers
in 1997 [9]. Nitrate rich diets including green leafy and
cruciferous vegetables were reported to have a protective
effect on cardiovascular diseases [11, 12].
Following the oral administration of sodium nitrate to
healthy volunteers, a significant fall in diastolic and
mean arterial blood pressure in association with increas-
ing plasma nitrate was previously demonstrated [13].
Beetroot, a vegetable with high organic nitrate content,
reduced blood pressure of healthy volunteers, an effect
that correlated with peak increases in plasma nitrite con-
centrations [14]. Intake of beetroot juice also signifi-
cantly attenuated ex vivo ADP- and collagen-induced
platelet aggregation [14]. In addition, it was demon-
strated that the reduction of nitrate to nitrite by oral
commensal bacteria was required for blood pressure
lowering and platelet inhibitory effects [14].
The formation of blood clot in the circulatory system
can lead to disturbances in the blood supply resulting in
embolism and stroke. Several fruit juices seem to be able
to limit blood clot formation by preventing platelet ag-
gregation in blood vessels [15, 16]. Fruit juices also play
a role in the maintenance of NO levels. This has been
shown to occur with many juices [17] including grape
[18], pomegranate [19], and citrus juices [20, 21]. These
beneficial changes have been noted at various aspects of
cardiovascular system including blood pressure [20, 22].
In the prevention of cardiovascular diseases, the con-
sumption of fruits and vegetables is crucial.
Guava (Psidium guajava L.) belongs to the family Myr-
taceae and is a traditionally used plant in tropical and
subtropical countries because of its food and nutritional
value. Every part of guava plant including leaves, root,
bark, and fruits has been used for medicinal purposes
[23]. The vasodilator and antioxidant actions exerted by
guava extracts have been reported [24]. Antihypertensive
effect of guava fruit (GF) on spontaneous hypertensive
rats was previously demonstrated [25]. Studies using
guava leaf extract showed cardio-protective effects
against myocardial ischemia-reperfusion injury in the
isolated rat heart [26] and cardio-inhibitory action in
rats and guinea pig models [27].
Yam bean (Pachyrhizus erosus L.) belongs to the family
Leguminosae, subfamily Papilionoidea. In Thailand, yam
bean’s tuberous root is consumed as fruit or vegetable.
There was limited study on pharmacological effects of
YBR. However, the crude fiber extract of YBR was
shown to enhance the production of IgM, IgG, IgA, IL-5
and IL-10 by mouse splenocytes [28]. However, there is
a lack of information regarding the effects of these plant
juices on cardiovascular and platelet functions.
In Thailand, various kinds of fruits are available, how-
ever; for public health concern, guava fruit and yam
bean root are appropriate for evaluating cardiovascular
benefits because they are available throughout the year,
not expensive, and thus consumable by all population.
The present study was designed to investigate effects of
ingesting juices from YBR and GF on heart rate (HR),
systolic blood pressure (SBP), diastolic blood pressure
(DBP), and platelet aggregation in healthy volunteers.
We also examined the possibility that increased plasma
nitrate can be achieved through the consumption of
these juices, which may consequentially lead to acute re-
duction of blood pressure and heart rate, and inhibition
of platelet aggregation, as a result of bioconversion to ni-
trite and NO in the body.
Methods
Chemicals
Adenosine diphosphate (ADP) and other chemicals were
purchased from Sigma (St Louis, MO). Chrono Par (col-
lagen) was purchased from Chrono-Log Corporation
(Havertown, PA). Cyclic GMP ELISA kit was purchased
from Assay Designs (Enzo Life Sciences, Inc., NY). Col-
lagen, nitrite preservation solution, sodium nitrite, so-
dium nitrate, and triiodide solution were prepared
freshly prior to use. ADP was dissolved in deionized
water as 10 mmole/L stock solution and kept at −20 °C.
Fruit materials and preparation of fruit juices
1. Pachyrhizus erosus L. (Common name: Yam bean;
Thai name: Mun-kaew; Cultivar: Small root)
2. Psidium guajava L. (Common name: Guava; Thai
name: Fa-rang; Cultivar: Pansetong)
Yam bean root (YBR) and guava fruit (GF) were pur-
chased from Talaad Thai Market, Pathumthani Province,
Thailand. Fruits were cleansed and juices were freshly
prepared prior to the study by mechanical squeezing the
fruit flesh with an electric juicer. Juices were then fil-
tered to remove fibers and pulps. The percentage yield
(% v/w) of juices from the fruit flesh was 47.62 % for
YBR and 71.67 % for GF.
Subjects
A sample size of 30 subjects completing the study was
employed on the basis of estimates from our preliminary
data. The sample size provided at least 95 % power to
demonstrate a difference between mean of the treatment
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values. The study protocol was approved by the Clinical
Research Ethics Committee of Ramathibodi Hospital,
Mahidol University (protocol number: ID 03-54-25) that
the study was conducted in compliance with the
Declaration of Helsinki. Individual subject provided an
informed consent after satisfying the inclusion criteria
and understanding that he or she could withdraw at any
time without a reason. The inclusion criteria were
healthy volunteers aged between 20 to 45 years, body
mass index (BMI) of 18–27 kg/m2, and singed informed
consent. The exclusion criteria were a history of any ser-
ious illnesses, including infectious diseases, cardiovascu-
lar and pulmonary diseases, smoking and/or alcoholic
drinking, systemic medication (other than oral contra-
ceptive pills), and pregnancy.
Study design
The study protocol, an open-label, randomized block de-
sign, was summarized as a flow chart in Fig. 1. The 30
subjects were randomly allocated into 3 trial groups
(n = 10 per group) to study the ingestion of 500 ml of
YBR juice, GF juice or water. For the allocation of
subjects, a drawing lots of subject list was used. Sub-
jects were asked to stop taking certain medications or
food supplements (e.g., NSAIDs, fish oil) for 14 days
prior to the study, and avoid taking food with high
nitrate contents such as processed meat or green leafy
vegetables on a day preceding the study. Subjects
were fasted overnight or at least 12 h prior to the
studying day and during the morning of that particu-
lar day. On the studying day, all subjects were in-
formed that the juice might cause a mild irritation
to their stomach. The study took place at Pharmaco-
logical Laboratory, Department of Pharmacology,
Faculty of Science, Mahidol University, under the
supervision and care of physicians.
Blood pressure measurement
Systolic blood pressure (SBP), diastolic blood pressure
(DBP) and heart rate (HR) were measured at the
baseline, and monitored every 30 min for 3 h, and
then at 5 h following juices or water ingestion. All
Fig. 1 The flow diagram of progress through phases of the study. Legend: Data monitoring at the baseline was performed prior to the water or
juice ingestion. (BP: blood pressure, HR: heart rate, YBR: yam bean root, GF: guava fruit)
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measurements were performed in triplicate with sub-
jects in the seated position using an automatic blood
pressure monitor (Omron, model T9P). The mean
values of second and third readings were used for
data analysis.
Blood sampling
Ten milliters of blood samples were taken via a 22G intra-
venous catheter with extension set at the baseline and at
0.5, 1, 1.5, 2, 2.5, 3, and 5 h after juice or water ingestion.
Blood samples were placed into lithium heparinized tubes
and citrate tubes for the plasma preparation and assess-
ment of platelet aggregation, respectively.
Determination of nitrate concentrations
To determine systemic nitrate concentrations, blood
samples were placed into heparinized tubes and gently
mixed. The heparinized blood were centrifuged at 5,000
g at 4 °C for 1 min and then the plasma was separated
and stored at −80 °C until the nitrate measurement. Ni-
trate concentrations were determined by a vanadium
chloride-based chemiluminescence NO analyzer (CLD
88 sp, Eco Medics, Switzerland) using sodium nitrate as
a standard [29]. Nitrate contents in juices and water
were determined by the same method.
Determination of nitrite concentrations
To determine systemic nitrite concentrations, blood
samples were placed into heparinized tubes, gently
mixed, and then centrifuged at 5,000 g for 1 min at 4 °C
to separate plasma [30, 31]. All samples were stored
at −80 °C until the nitrite measurement. Nitrite con-
centrations were determined by a triiodide-based
chemiluminescence NO analyzer (CLD 88 sp, Eco
Medics, Switzerland) using sodium nitrate as a stand-
ard [30]. Nitrite contents in juices and water were de-
termined by the same method.
Platelet aggregation study
Blood samples were collected from healthy volunteers
and placed in plastic tubes containing 3.8 % sodium cit-
rate in a ratio of 9:1 v/v. Platelet aggregation was
assessed in platelet-rich plasma (PRP) which was pre-
pared by centrifugation of citrated blood at 200 g for
10 min at 25 °C and the portion of platelet-rich super-
natant was collected. The remaining portion was further
centrifuged at 5,000 g for 10 min at 25 °C to obtain
platelet-poor plasma (PPP). ADP (1–4 μmole/L) and
collagen (0.5–2 μg/ml) were used as agonists for platelet
aggregation. The PRP was incubated for 2 min at 37 °C,
calibrated for 100 % light transmission against PPP,
stirred for 1 min at a speed of 1,000 rpm prior to the
addition of a platelet agonist (ADP or collagen).
Platelet aggregation was monitored by a Chrono-Log
aggregometer (Model 540 VS, Chronolog Corp., USA)
using the optical aggregation technique as previously
described [32, 33].
Determination of plasma cGMP concentrations
Plasma cGMP levels were determined by using an
enzyme immunoassay (Assay Designs' Correlate-EIA™
cyclic GMP kit) according to the manufacturer’s instruc-
tion. The heparinized blood samples were immediately
centrifuged at 5,000 g for 1 min at 4 °C to separate
plasma. Plasma samples were kept below −20 °C until
the assay.
Determination of serum potassium concentrations
Serum potassium ion levels were determined using
an automated biochemical analyzer (Hitachi, model
912) which based on the ion-selective electrode tech-
nique [34].
Statistical analysis
All data were analyzed using the Graph Pad Prism Soft-
ware 5.01 and expressed as mean ± SEM. Data were
compared by repeated measures ANOVA test followed
by Dunnett’s posttest for comparison with baseline
values, and followed by Bonferroni posttest for compari-
son with the control group. The value P < 0.05 was con-
sidered as statistically significant.
Results and discussion
Results
At the baseline, there was no significant difference in
general characteristics among subjects in each group
(Table 1). Both YBR and GF juices were palatable and
well tolerated by all subjects. The mean (± SEM) con-
centrations of nitrate in YBR and GF juices were 5.231
(±0.173) and 0.355 (±0.030) mmole/L, respectively.
However, nitrite contents of fruit juices and water were
below the detection limit (<50 nmole/L) of the analytical
assay.
Systemic nitrate, systemic nitrite, and serum K+
concentrations
At the baseline, systemic nitrate concentrations in all
subject groups were within the normal range, and there
was no significant difference among them (Table 1).
After YBR juice ingestion, as compared to the control
group, there was a rapid and significant (P < 0.05) rise of
systemic nitrate concentrations, starting within 30 min,
peaking at 1.5 h and remaining at this level up to 5 h
(Fig. 2a). However, there was no similar change after GF
juice ingestion (Fig. 2a).
Baseline systemic nitrite concentrations of all subject
groups were within the normal range (100–500 nmole/
L) [35] and there was no significant difference among
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them (Table 1). Following YBR juice ingestion, as com-
pared to the control group, systemic nitrite levels in-
creased significantly (P < 0.05) after 1.5 h, peaking at
2.5 h (4.5 folds), remaining at this level up to 3 h then
returned to near the baseline value by 5 h (Fig. 2b).
There was no change in systemic nitrite concentrations
after the ingestion of GF juice (Fig. 2b).
Baseline serum K+ concentrations of all subject groups
were shown in Table 1. There was no significant differ-
ence among them. In addition, no significant alteration
of serum K+ levels in healthy volunteers was apparent
after the ingestion of YBR juice, GF juice, or water (data
not shown).
Effects on ex vivo platelet aggregation
The mean platelet count of all subject groups was within
the normal range (2–4 × 103 per ml of the whole blood)
and there was no significant difference among them
(Table 1). At the baseline (t = 0 h), ADP dose-
dependently induced the platelet aggregation with no
difference in platelet responses among three subject
groups (Fig. 3a, b and c). Both YBR and GF juices did
not cause any significant alteration of the platelet aggre-
gation induced by ADP (Fig. 3a, b and c).
Collagen dose-dependently induced the platelet aggre-
gation with no difference in platelet responses among
three subject groups at the baseline (Fig. 4a, b and c).
Following the ingestion of both YBR and GF juices, the
ex vivo collagen-induced platelet aggregation was signifi-
cantly attenuated (P < 0.05) as compared to that of con-
trol (Fig. 4a, b, and c).
Effects on plasma cGMP concentrations
Plasma cGMP concentrations were measured in all sub-
ject groups prior to the ingestion of juices or water.
There was no significant difference in baseline
plasma cGMP concentrations among three subject
groups (Table 1). The YBR juice ingestion caused a
slight but significant (P < 0.05) increase of plasma
cGMP over the baseline value at 2.5 h and then it
declined towards the baseline at 5 h (Fig. 5). In
comparison with the control group, the plasma
cGMP concentration at 2.5 h after the ingestion was
significantly higher in YBR group. However, there
was no significant change of the plasma cGMP after
the ingestion of GF juice (Fig. 5).
Systemic nitrite concentrations vs. plasma cGMP
concentrations
After the YBR juice ingestion, a significant and positive
correlation (P < 0.05) between the increase of systemic
nitrite concentrations and the increase of plasma cGMP
concentrations was evident (Fig. 6). However, no correl-
ation between these two variables was found after the in-
gestion of GF juice (data not shown).
Plasma cGMP concentrations vs. collagen-induced platelet
aggregation
Correlations between systemic nitrate, systemic nitrite,
or plasma cGMP concentrations vs. the magnitude of ex
vivo collagen-induced platelet aggregation were exam-
ined. Results showed a significant and negative correl-
ation (P < 0.05) between plasma cGMP concentrations
and the maximum extent of platelet aggregation induced
by varying concentrations of collagen – 0.5 μg/ml
(Fig. 7a), 1 μg/ml (Fig. 7b) and 2 μg/ml (Fig. 7c), in YBR
juice group. No correlation between these two variables
was found in GF juice group (data not shown).
Table 1 Demographic characteristics of healthy volunteers at the baseline
Characteristics Water (control) YBR juice GF juice Significance value
Subject (n) 10 10 10 P > 0.05
1. Male 3 3 4 P > 0.05
2. Female 7 7 6 P > 0.05
Age (year) 27.2 ± 2.4 26.0 ± 2.9 25.4 ± 2.2 P > 0.05
Height (cm) 163.67 ± 8.34 164.92 ± 7.83 166.11 ± 6.92 P > 0.05
Weight (kg) 62.04 ± 12.28 61.17 ± 9.88 63.11 ± 11.33 P > 0.05
BMI (kg/m2) 23.07 ± 3.75 22.45 ± 2.30 22.78 ± 3.37 P > 0.05
Platelet × 105 (per ml of WB) 2.19 ± 0.55 2.21 ± 0.62 2.50 ± 0.39 P > 0.05
Plasma nitrate (μmole/L) 30.16 ± 4.31 36.43 ± 5.32 30.35 ± 1.78 P > 0.05
Plasma nitrite (nmole/L) 124.04 ± 9.31 106.87 ± 18.40 140.12 ± 2.11 P > 0.05
Plasma cGMP (nmole/L) 5.37 ± 0.50 5.613 ± 2.15 6.97 ± 2.50 P > 0.05
Serum K+ (mmole/L) 3.98 ± 0.132 4.09 ± 0.10 4.01 ± 0.08 P > 0.05
Data are expressed as mean ± SEM from subjects in each group. Baseline values were measured at time points prior to YBR juice, GR juice, or water ingestion.
Statistical analysis was performed using unpaired Student’s t-test vs. the control
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Effects on SBP, DBP and HR
Effects of YBR and GF juice consumption on SBP, DBP
and HR were observed in healthy volunteers. At the
baseline, there was no difference in means (± SEM) of
SBP, DBP and HR among healthy subjects in all groups
(Table 2). Comparing with the water control, a signifi-
cant reduction (P < 0.05) of DBP was apparent only at
0.5 h after YBR juice intake but not at other time points
(Fig. 8c). YBR juice ingestion caused no change in SBP
(Fig. 8a) or HR (Fig. 8e) as compared to baseline values.
On the contrary, the ingestion of GF juice significantly
(P < 0.05) reduced SBP (Fig. 8b), DBP (Fig. 8d) and HR
(Fig. 8f ) at many time points as compared to baseline
values. However, only SBP reduction at 5 h after GF
juice intake was significantly (P < 0.05) different from
that of control (Fig. 8b).
Discussion
Following the ingestion of YBR juice but not GF juice,
systemic nitrate concentrations increased rapidly (within
30 min, peaking at 1.5 h). Our results were in accord-
ance with previous studies which showed that dietary
nitrate was readily absorbed from the stomach and prox-
imal intestine into the blood [13, 14]. Systemic nitrite
concentrations, however, increased slowly (within 1.5 h),
Fig. 3 Effects of the juice ingestion on ex vivo ADP-induced platelet
aggregation. Legend: Ex vivo ADP-induced platelet aggregation after
the ingestion of water (a), YBR juice (b), or GF juice (c). Data are
expressed as mean ± SEM from 10 subjects in each group. aP < 0.05
Dunnett’s posttest compared to the baseline
Fig. 2 Time-plasma concentration profiles of nitrate and nitrite.
Legend: Plasma nitrate (a) and plasma nitrite (b) concentrations in
healthy volunteers at various time points after the ingestion of
water, YBR juice, or GF juice. Data are expressed as mean ± SEM
from 10 subjects in each group. aP < 0.05 Dunnett’s posttest
compared to the baseline, bP < 0.05 Bonferroni posttest vs.
the control
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peaked at 2.5–3 h and returned to the baseline value at
5 h. Since ingested YBR juice contains substantial
amount of nitrate with undetectable quantity of nitrite,
it was unlikely that systemic nitrite originated from
absorbed dietary nitrite. In addition, following the inges-
tion of YBR juice, levels of plasma nitrite were elevated
later than those of plasma nitrate (1.5 h vs. 30 min),
reflecting the bioconversion of nitrate to nitrite in the
body. Our observation was consistent with studies using
inorganic nitrate and dietary nitrate (beet root juice) [13,
14]. Previous studies showed that systemic nitrite can be
derived from the reduction of nitrate, originated either
from NO or diet, to nitrite by two routes. Firstly, nitrate
can be reduced to nitrite by commensal facultative an-
aerobic bacteria present in the oral cavity (i.e. mouth)
and possibly in the gastrointestinal tract [36–38]. In a
recent cross-over designed study with seven healthy hu-
man volunteers, rinsing the mouth with an antibacterial
mouth wash has been shown to abolish conversion of ni-
trate to nitrite in the saliva, and markedly reduce in-
crease in plasma nitrite following a dietary nitrate load
Fig. 4 Effects of the juice ingestion on ex vivo collagen-induced
platelet aggregation. Legend: Ex vivo collagen-induced platelet
aggregation after the ingestion of water (a), YBR juice (b), or GF
juice (c). Data are expressed as mean ± SEM from 10 subjects in
each group. aP < 0.05 Dunnett’s posttest compared to the baseline
Fig. 5 Effects of the juice ingestion on plasma cGMP concentrations.
Legend: Plasma cGMP concentrations at three time points – baseline,
2.5 and 5 h after the ingestion of water, YBR juice, or GF juice. Data
are expressed as mean ± SEM from 10 subjects in each group.
aP < 0.05 Dunnett’s posttest compared to the baseline, bP < 0.05
Bonferroni posttest vs. the control
Fig. 6 The association between plasma cGMP and plasma nitrite
concentrations. Legend: A positive correlation between the change
of plasma cGMP concentrations vs. the change of circulating
nitrite concentrations in healthy volunteers following YBR juice
ingestion (n = 10)
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[38]. It is thus suggested that oral bacteria play a crucial
role in the reduction of nitrate to nitrite and contribute
to systemic nitrite levels. Secondly, the other possibility
for systemic nitrate reduction to nitrite is nitrate reduc-
tase enzymes present in tissues such as lung, liver, heart,
and kidney [39]. It was demonstrated that mammalian
tissues reduce inorganic nitrate to nitrite and this effect
was significantly inhibited by allopurinol, suggesting that
molybdenum-based oxidoreductase enzymes, such as
xanthine oxidase, present in mammalian tissues may
catalyze, at least in part, the reduction of nitrate to ni-
trite and contribute to systemic nitrite levels. In har-
mony with previous studies, the present study suggested
that following the ingestion of YBR juice the nitrate con-
tent in YBR juice was absorbed and was further con-
verted to nitrite in the body.
In this study, we have shown that both YBR and GF
juices attenuated ex vivo collagen-induced platelet aggre-
gation. However, only the inhibition by YBR juice at
2.5 h after the ingestion was concurrent with the peak-
ing of systemic nitrite concentrations. Moreover, at 5 h
after YBR juice ingestion, both systemic nitrite concen-
trations and collagen-induced platelet aggregation were
simultaneously returned to baseline values. Supplemen-
tation with 2 mmole/L potassium nitrate has been dem-
onstrated to inhibit platelet aggregation [40]. Dietary
supplement with nitrate (beetroot juice) has been shown
to inhibit ex vivo platelet aggregation in healthy volun-
teers [14]. Moreover, nitrite was shown to inhibit platelet
aggregation in a cat model [41]. Our results suggest that
systemic nitrite derived from dietary nitrate in YBR juice
may involve in the mechanism of platelet inhibition.
Recently, Sihirun et al. [42] showed that nitrite itself
did not directly inhibit platelet aggregation in vitro and
suggested that nitrite might be further converted to NO
which attenuated platelet aggregation. Cosby et al. [43]
demonstrated increased NO formation in the blood, as
measured by the rate of formation of ironnitrosylated
hemoglobin (HbNO) during nitrite infusion at rest and
under exercise, suggesting that nitrite represents a major
bioavailable pool of NO. Recently, it was shown that
inorganic nitrate ingestion in males elevated platelet
cGMP levels, implicating a role of NO in the anti-
aggregating effect of nitrate in vivo [44]. Accordingly, we
demonstrated that following YBR juice ingestion, similar
concentration-time profiles of systemic nitrite and
plasma cGMP were apparent. In addition, a positive cor-
relation (r = 0.6509, P < 0.05) between the extent of in-
creases in plasma nitrite from the baseline and the
extent of increases in plasma cGMP from the baseline
was evident. Nitrate was previously shown to increase
the plasma cGMP [45]. Arteriolar cGMP production has
been used to assess the activation of soluble guanylyl
cyclase in vivo [45]. Many investigators adopted nitrate
and plasma cGMP measurements as a reliable indicator
of NO amplification during physiological [4, 7] and
pharmacological stimulations [5, 8]. Moreover, a
previous study showed that collagen-induced platelet
adhesion and aggregation were inhibited by NO donor
S-nitrosoglutathione (GSNO) [46]. Our results also
showed the negative correlation between plasma cGMP
concentrations and the maximal extent of ex vivo plate-
let aggregation induced by varying concentrations of
collagen (0.5–2 μg/ml) in YBR juice group. During
Fig. 7 The association between plasma cGMP concentrations and
collagen-induced platelet aggregation. Legend: The negative correl-
ation between plasma cGMP concentrations and the maximal extent
of platelet aggregation (% Light transmission) induced by (a) 0.5 μg/ml
collagen (b) 1 μg/ml collagen and (c) 2 μg/ml of collagen in YBR juice
ingested volunteers (n = 10)
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inhalation of NO, increased plasma cGMP concentra-
tions and inhibition of platelet aggregation have been
previously reported [47, 48]. Therefore, results of the
present study in conjunction with previous studies sug-
gested that following YBR ingestion, systemic nitrite that
converted from systemic nitrate was further converted
to NO which attenuated platelet responses to collagen
stimulation. On the contrary, our results demonstrated
that YBR juice intake did not inhibit ADP-induced plate-
let aggregation.
The ingestion of GF juice also attenuated collagen-
induced but not ADP-induced platelet aggregation.
Table 2 Time courses of SBP, DBP and HR values before and after YBR, GF, or water ingestion
Time
(h)
SBP (mmHg) DBP (mmHg) HR (beats/min)
Control YBR GF Control YBR GF Control YBR GF
0 103.10 111.90 116.20 69.30 72.00 73.22 76.70 74.10 77.11
±3.38 ±3.25 ±2.71 ±2.82 ±2.46 ±1.95 ±3.07 ±3.64 ±3.36
0.5 108.50 112.90 114.10 70.90 64.70a,b 68.44 75.30 69.80 72.44
±3.58 ±2.98 ±3.25 ±2.86 ±4.15 ±2.29 ±2.77 ±4.55 ±1.58
1 106.40 110.70 113.50 69.10 68.70 68.00 77.50 74.60 76.78
±2.84 ±2.98 ±2.64 ±2.24 ±1.89 ±1.61 ±3.60 ±4.99 ±3.53
1.5 106.50 106.60 111.40 70.30 67.70 71.11 77.00 73.90 75.11
±2.81 ±3.20 ±2.07 ±3.09 ±2.65 ±3.14 ±3.43 ±4.10 ±1.52
2 102.80 109.00 107.10 68.10 67.00 65.56a 75.70 72.20 74.33
±3.61 ±3.62 ±3.04 ±2.84 ±1.61 ±2.50 ±2.89 ±4.04 ±2.43
2.5 105.50 106.50 110.10a 71.00 66.30 67.67 73.80 69.80 71.56a
±2.24 ±3.13 ±3.21 ±2.69 ±2.51 ±1.77 ±2.69 ±3.94 ±2.65
3 101.20 105.70 111.50 65.90 67.50 65.33a 73.80 70.90 72.11a
±1.65 ±2.28 ±2.13 ±1.88 ±3.08 ±1.43 ±3.50 ±4.04 ±2.17
5 106.50 106.60 108.50a,b 70.00 69.30 68.67 74.80 69.70 69.78a
±2.32 ±1.99 ±2.77 ±2.54 ±2.13 ±1.41 ±3.99 ±4.07 ±2.15
Data are expressed as mean ± SEM from 10 subjects in each group. aP < 0.05 Dunnett’s posttest compared to the baseline, bP < 0.05 Bonferroni posttest vs.
the control
Fig. 8 Acute cardiovascular changes after the juice ingestion. Legend: Effects of YBR juice ingestion on - SBP (a), DBP (c) and HR (e); effects of GF
juice ingestion on - SBP (b), DBP (d) and HR (f) as compared to the control. Data are expressed as mean ± SEM from 10 subjects in each group.
aP < 0.05 Dunnett’s posttest compared to the baseline, bP < 0.05 Bonferroni posttest vs. the control
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However, our results showed that the inhibition of
collagen-induced platelet aggregation by GF was not as-
sociated with systemic nitrate and nitrite concentrations.
Guava is a flavonoid-rich fruit [49, 50], and flavonoid
compounds existed in guava fruit were reported
including myricetin, apigenin, leucocyanidin, quercetin,
quercetin-3-α-L arabinofuranoside, quercetin 3-β-D
glucoside, quercertin 3-β-galactoside, and quercitrin [50,
51]. Hubbard and coworkers [52] proposed that the
ingestion of quercetin-4-o-β-d-glucoside inhibited collagen-
induced platelet aggregation via the reduction in phosphor-
ylation of tyrosine kinase Syk and phospholipase Cγ2,
which are signaling components of the platelet glycoprotein
VI collagen receptor. In addition, some studies suggested
possible mechanisms by which flavonoids exert their
antiplatelet property; lowering intracellular Ca2+ levels,
alteration in the metabolism of cAMP and thromboxane
A2 [53, 54]. It is likely that flavonoids in GF juice might be
responsible for the platelet inhibitory action, a speculation
that requires further investigations.
Webb and coworkers [14] demonstrated that the in-
gestion of nitrate load (beetroot juice) reduced both sys-
tolic and diastolic blood pressure in healthy human
volunteers, an effect that correlated with the peak in-
crease in plasma nitrite concentrations. Our study
showed that YBR juice reduced DBP only at 0.5 h after
the ingestion and this response showed no association
with both nitrate and nitrite concentrations. Lacking of
cardiovascular effects of YBR juice may be due to rela-
tively low systemic concentrations of both nitrate and
nitrite after YBR ingestion as compared to those of beet
root juice. Peak concentrations of systemic nitrate and
nitrite after YBR juice ingestion were 150 μmole/L and
0.4 μmole/L, respectively, and those after beetroot juice
ingestion were 400 μmole/L for systemic nitrate and 0.6
μmole/L for systemic nitrite. In general, it is rather diffi-
cult to see changes of cardiovascular responses induced
by low concentrations of these substances in healthy vol-
unteers. However, these variables may be altered by
emotional changes, the position of subjects, as well as
pathological conditions. Our results showed that GF
juice ingestion affected all cardiovascular variables mea-
sured. The effect of GF juice on SBP in the present study
is supported by a previous study which showed the anti-
hypertensive effect of pink guava puree in spontaneous
hypertensive rats [25]. Vasodilator and antioxidant ac-
tions exerted by the guava extract have also been re-
ported [24]. In patients with essential hypertension,
guava extracts supplemented for twelve weeks signifi-
cantly decreased SBP with a significant increase in HDL
[55]. Our results also demonstrated the cardiac depres-
sive effect of GF juice intake. Similarly, guava leaf extract
was previously demonstrated to have cardiac depressant
activities in the cardiac tissue [27] and animal model
[56]. Overall, the apparent limitation of our study is
using a relatively small number of subjects per group
which might lead to the arbitrary generalization of study
outcome.
Conclusion
The present study showed, for the first time, the acute
platelet inhibitory effect of YBR juice and GF juice inges-
tion in healthy volunteers. YBR juice contained a sub-
stantial amount of dietary nitrate which, following
ingestion, was absorbed and further converted to nitrite
in the body. Systemic nitrite might be further converted
to NO which attenuated platelet responses to collagen
stimulation following YBR juice ingestion. In addition,
the ingestion of YBR juice reduced only DBP while the
ingestion of GF juice reduced SBP, DBP and HR. As our
concern on primary prevention, the consumption of
YBR and GF juices might promote public cardiovascular
health through their roles in platelet inhibition and
blood pressure lowering. Further works are needed to
fully elucidate the molecular mechanism of actions of
YBR and GF juices in several physiological processes in
order to prove their prophylactic and therapeutic
potentials.
Abbreviations
cGMP, cyclic guanosine monophosphate; DBP, diastolic blood pressure; GF,
guava fruit; HR, heart rate; NO, nitric oxide; SBP, systolic blood pressure; YBR,
yam bean root
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